- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06803576
Clinical and Microbiological Outcomes of Dental Implants After 10-22 Years of Function
Clinical and Microbiological Parameters of Success Following the Application of Osseointegrated Dental Implants. a 10-year Retrospective Study
Aim: the aim of this retrospective study is to present long-term data (10+ years of functional loading) on the success and survival of ZimVie (3i) implants. Data from a patient pool of a private periodontal office will be used to reexamine patients with at least 10 years of loading of their dental implants.
Parameters to be examined are bone loss, biologic and prosthetic complications, as well as Patient Reported Outcomes (PROMs) to analyze patient satisfaction with dental implant treatment
Study Overview
Status
Conditions
Detailed Description
Aim: the aim of this study is to present long-term data (10+ years of functional loading) on the success and survival of ZimVie (3i) implants.
Clinical relevance: The successful application of dental implants in replacing missing teeth has been proven since the late 1980's. Over the years a great number of changes in implant designs and implant companies have entered in the dental field of practice. One of the most important questions that have to be addressed is the long-term stability and success of dental implants. While some implant brands have shown reliable long-term stability of their implants, there is still a lack of long-term studies (over 10 years of functional loading) for many implant systems, as it is quite hard to follow-up on patients for such a long time. Therefore, long-term data on implant survival and success is particurarly useful, especially if it is based on private practice patient, thus reflecting the aspects of everyday practice of implantology
Materials and methods: A comprehensive search of patient records from the private practice of the primary investigator (A.B.) was conducted and patients that received dental implant placement from 2001 until 2013 will be asked to participate in the study. After signing the relevant consent forms, all patients that are willing to participate in the study will be examined clinically and radiographically. The following parameters will be examined:
- Age, sex of patient
- Relevant medical history
- Smoking history
- Compliance to recall appointments
- Early implant losses
- Years of prosthetic loading of implants
- Implant characteristics (length, diameter, surface, cylindrical or root-shaped)
- Type of prosthesis (single or multiple abutments, cemented or screw-retained)
- Biological complications (mucositis, peri-implantitis)
- Prosthetic complications (minor, moderate or severe)
- History of periodontal disease and treatment prior or after implant placement
- Prosthetic work performed by specialist or general practitioner
- Maintenance performed by specialist or general practitioner
- Relevant ridge augmentation procedures during or before implant placement
- Clinical measurements (Pocket depth, Attachment loss, Bleeding on probing, presence of Plaque) on six site for every implant (MB, B, DB, ML, L, DL)
- Samples of the peri-implant sulcular fluid will taken with paper points and measured with Elisa kits to calculate the presence of the following biomarkers: RANKL, OPG, Il-a and TNF-b
- A radiograph will be taken with the parallel cone technique and compared to baseline xrays after implant placement to measure bone stability
- A questionnaire will be also provided to all study participants to measure satisfaction following implant therapy Data analysis The main parameter to be examined will be bone loss around an implant over time, as that relates to the definitions of peri-implant mucositis and peri-implantitis. Secondary outcomes will also be examined as pertaining to clinical differences according to the variety of 3i implants that have been used. External vs. internal hex, root-shape vs cylindrical, osseotite vs full osseotite vs nanotite surfaces etc. An number of around 100 patients are expected to be examined for a total of 250 implants.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Locations
-
-
-
Thessaloniki, Greece, 54124
- School of Dentistry
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age 18 years and over
- Systemic health or controlled medical conditions
- Periodontal health, either no periodontal disease, or previously treated periodontal disease under a supportive periodontal maintenance (SPT) program
- Smokers were included but encouraged to enter a smoking cessation program
- Patients with bruxism or parafunctional habits were included.
Exclusion Criteria:
- Uncontrolled medical conditions
- Active uncontrolled periodontal disease
- Inability to present for the reevaluation appointment
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Patients with a least 10 years of loaded implants
Patients from a private periodontal office who have functioning implants for at least 10 years (range 10-22 years)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Radiographic Marginal Bone loss
Time Frame: 10-22 years
|
The amount of vertical bone loss around the mesial and distal surface of an implant, when bone levels at time of placement and at reevaluation were compared
|
10-22 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Implant Survival and Success Rates
Time Frame: 10-22 years
|
Implant Survival Rate was defined as an implant still in place at the time of reevaluation and Implant Success Rate was defined as an implant with marginal bone loss up to 2 mm
|
10-22 years
|
|
Incidence of peri-implant pathology
Time Frame: 10-22 years
|
The percentages of implants that are healthy, have peri-implant mucositis or peri-implantitis
|
10-22 years
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient-Reported Outcome Measures
Time Frame: 10-22 years
|
Patients will fill out a questionnaire with 13 targeted questions pertaining to their satisfaction with implant treatment.
Patients circled one of the possible answers to each question ("Yes, definitely", "Enough", "Not so", "Definitely not", "Don't know", "No anwswer")
|
10-22 years
|
Collaborators and Investigators
Investigators
- Principal Investigator: Ioannis Vouros, DDS PHD, Aristotle University of Thessaloniki
Publications and helpful links
General Publications
- Amelie Bäumer1,2*, Shirin Toekan3, Daniel Saure4 and Gerd Körner2
- Carra MC, Blanc-Sylvestre N, Courtet A, Bouchard P. Primordial and primary prevention of peri-implant diseases: A systematic review and meta-analysis. J Clin Periodontol. 2023 Jun;50 Suppl 26:77-112. doi: 10.1111/jcpe.13790. Epub 2023 Mar 6.
- Chappuis V, Buser R, Bragger U, Bornstein MM, Salvi GE, Buser D. Long-term outcomes of dental implants with a titanium plasma-sprayed surface: a 20-year prospective case series study in partially edentulous patients. Clin Implant Dent Relat Res. 2013 Dec;15(6):780-90. doi: 10.1111/cid.12056. Epub 2013 Mar 18.
- Frisch E, Vach K, Ratka-Krueger P. Impact of supportive implant therapy on peri-implant diseases: A retrospective 7-year study. J Clin Periodontol. 2020 Jan;47(1):101-109. doi: 10.1111/jcpe.13206. Epub 2019 Nov 6.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 458/16-4-2021
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bone Loss in Jaw
-
Menoufia UniversityMansoura UniversityRecruiting
-
Amira ragabEnrolling by invitation
-
Ain Shams UniversityFayoum University; Egyptian Russian UniversityActive, not recruiting
-
University of BelgradeEnrolling by invitation
-
Wishbone SAUnknown
-
Ain Shams UniversityEgyptian Russian UniversityCompleted
-
Cairo UniversityUnknown
-
Damascus UniversityCompletedImplant Site Reaction | Bone Loss in JawSyrian Arab Republic
-
Cairo UniversityCompleted
-
Istanbul Saglik Bilimleri UniversityEnrolling by invitationPeriodontal Diseases | Periodontal Atrophy | Laser Therapy | Periodontal Bone Loss | Alveolar Bone Loss | Bone Loss in JawTurkey (Türkiye)